The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

2018 
Background The aim of the present study was to investigate the association between matrix metalloproteinase-9 (MMP-9) expression with BRAF V600E mutation and clinicopathological features, in Iranian papillary thyroid cancer (PTC) patients.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    37
    References
    13
    Citations
    NaN
    KQI
    []